주식/증권 📈 긍정적

Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications

MarketWatch - Top Stories 07/21/2026 12:27:00 PM 2회

요약

The Danish company Novo says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.

원문 기사 보기

관련 뉴스

MDA Space wins contract to supply lunar landing sensors for ESA's Argonaut mission

IXUS vs. NZAC: Broad International Exposure or Climate-Focused Investing -- Which ETF Is the Better Buy?

Alibaba-backed Moonshot considering new funding at $50B valuation: report

Cemex rejects price collusion alleged by European Commission

뉴스 목록으로